NHS England has launched a 12-week consultation on draft proposals outlining a new Cancer Drugs Fund (CDF). The aim of the new CDF is to help patients receive new treatments with genuine promise, while real world evidence is collected for up to two years on how well they work in practice. This will then help determine whether the treatment should be accepted for routine use in the NHS in the future. The consultation period runs until 11 February 2016.
Additional link: NICE press release